Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;16(10):2394-400.
doi: 10.1111/j.1582-4934.2012.01554.x.

Suppression of high lipid diet induced by atherosclerosis sarpogrelate

Affiliations

Suppression of high lipid diet induced by atherosclerosis sarpogrelate

Yan-Jun Xu et al. J Cell Mol Med. 2012 Oct.

Abstract

Sarpogrelate (SP), a serotonin (5-HT2A) receptor antagonist, is used as an anti-platelet agent for the treatment of some vascular diseases. SP has been reported to inhibit 5-HT induced coronary artery spasm, increase in intracellular calcium and smooth muscle cells proliferation. This study was undertaken to test that SP suppresses the development of atherosclerosis due to high cholesterol diet (HCD) by decreasing blood viscosity and oxidative stress. For this purpose, 29 rabbits were divided into four groups: control group (normal diet); normal diet group with SP at the dose of 5 mg/kg/day; HCD group fed 1% cholesterol; and HCD group with SP at the dose of 5 mg/kg/day. After 90 days of the experiment, blood samples were collected and the animals were killed; the thoracic aorta was stained by the Oil Red O staining method. The results indicate that plasma levels of cholesterol, triglycerides and malondialdehyde were increased in rabbits fed HCD. Plasma viscosity and whole blood viscosity were also higher in the HCD group than that in normal diet group. Treatment with SP prevented these alterations induced by HCD whereas this agent had no significant effect in rabbits fed normal diet. Morphological examination of the aorta revealed that SP treatment prevented the formation of foam cells and atherosclerotic plaque. It is suggested that the beneficial effects of SP in atherosclerosis may be due to actions on blood viscosity, lipid levels and oxidative stress.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Effects of sarpogrelate on high cholesterol diet induced changes in plasma cholesterol and triglyceride levels in rabbits. Con, control; SP, sarpogrelate (5 mg/kg/day); HCD, high cholesterol (1%) diet for 90 days, *P < 0.05 versus cont; #P < 0.05 versus HCD. Each value is a mean ± SE of 4–12 animals in each group as indicated in the Methods section.
Fig 2
Fig 2
Effects of sarpogrelate on high cholesterol diet induced changes in plasma malondialdehyde and superoxide dismutase levels in rabbits. All abbreviations are same as in Fig. 1.
Fig 3
Fig 3
Effects of sarpogrelate on high cholesterol diet induced changes in whole blood and plasma viscosity in rabbits. cP – centipoise. All abbreviations are same as in Figure 1.
Fig 4
Fig 4
Representative illustration showing the effects of sarpogrelate on high cholesterol diet induced formation of atherosclerotic plaque in thoracic aorta of rabbits.
Fig 5
Fig 5
Representative illustration showing the effects of sarpogrelate on high cholesterol diet induced formation of atherosclerotic plaque in aortic arch of rabbits.
Fig 6
Fig 6
Representative illustration showing the effects of sarpogrelate on high cholesterol diet induced foam cells and lipid deposits in aortic arc.

Similar articles

Cited by

References

    1. Saini HK, Takeda N, Goyal RK, et al. Therapeutic potentials of sarpogrelate in cardiovascular disease. Cardiovasc Drug Rev. 2004;22:27–54. - PubMed
    1. Sharma SK, Zahradka P, Chapman D, et al. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther. 1999;290:475–81. - PubMed
    1. Nagatomo T, Rashid M, Muntasir HA, et al. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. Pharmacol Ther. 2004;104:59–81. - PubMed
    1. Sanganalmath SK, Barta J, Takeda N, et al. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myoscardial infarction. Can J Physiol Pharmacol. 2008;86:180–9. - PubMed
    1. Nishihira K, Yamashita A, Tanaka N, et al. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J Thromb Haemost. 2006;4:247–55. - PubMed

Publication types

MeSH terms